Zorevunersen Cuts Convulsive Seizures in Children With Dravet Syndrome
The investigational antisense therapy reduced convulsive-seizure frequency by up to 90.91% and improved adaptive behavior over 36 months.
Finerenone Reduces Albuminuria in Type 1 Diabetes and CKD
A phase 3 trial shows the mineralocorticoid receptor antagonist finerenone safely lowers albuminuria in adults with type 1 diabetes.
Baxdrostat Reduces 24-Hour Blood Pressure in Resistant Hypertension
A phase 3 trial shows the selective aldosterone synthase inhibitor baxdrostat reduces systolic blood pressure by 14 mm Hg versus placebo.
Neoadjuvant GOLP Doubles Event-Free Survival in Cholangiocarcinoma
Administering the GOLP regimen before surgery extends median event-free survival to 18 months in high-risk intrahepatic cholangiocarcinoma.
Hybrid Dialectical Behavior Therapy Reduces Suicidal Ideation in Adolescents
A year-long trial shows combining online and offline DBT improves emotional regulation and depressive symptoms in self-injuring youth.
Apixaban Reduces Bleeding Risk Versus Rivaroxaban in Venous Thromboembolism
In a randomized trial of 2,760 patients, apixaban resulted in a 3.3% bleeding rate compared to 7.1% for rivaroxaban over three months.
Romiplostim Prevents Chemotherapy Dose Reductions in Gastrointestinal Cancers
A phase 3 trial shows romiplostim maintains platelet counts, allowing patients to receive full oxaliplatin-based chemotherapy doses.
Inhaled Treprostinil Slows FVC Decline in Idiopathic Pulmonary Fibrosis
A phase 3 trial shows inhaled treprostinil preserves forced vital capacity and reduces clinical worsening over 52 weeks versus placebo.
Clozapine Increases Response After One Failed Antipsychotic in Early Psychosis
A sequential trial reveals that switching to clozapine after a single failed antipsychotic yields a 62.5% response rate in early psychosis.
Trial: Higher Bupivacaine Doses Do Not Improve Nerve Block Headache Relief
A randomized trial finds that low-dose, unilateral sphenopalatine ganglion blocks are as effective as higher doses for acute headaches